Manchester Capital Management’s Biogen BIIB Stock Holding History

Manchester Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$165K	Sell	901 -3	-0.3%	-$553	0.02%	294
2025 Q4	$159K	Buy	904 +26	+3%	+$4.25K	0.02%	300
2025 Q3	$123K	Buy	878 +4	+0.5%	+$541	0.02%	382
2025 Q2	$110K	Sell	874 -24	-3%	-$2.99K	0.01%	435
2025 Q1	$123K	Buy	898 +12	+1%	+$1.72K	0.02%	403
2024 Q4	$135K	Sell	886 -22	-2%	-$3.71K	0.02%	394
2024 Q3	$176K	Buy	908 +7	+0.8%	+$1.46K	0.02%	355
2024 Q2	$209K	Sell	901 -6	-0.7%	-$1.3K	0.03%	301
2024 Q1	$196K	Buy	907 +74	+9%	+$17.3K	0.02%	316
2023 Q4	$216K	Buy	833 +17	+2%	+$4.17K	0.03%	272
2023 Q3	$210K	Buy	816 +150	+23%	+$40.1K	0.03%	259
2023 Q2	$190K	Hold	666	–	–	0.03%	277
2023 Q1	$185K	Hold	666	–	–	0.02%	296
2022 Q4	$184K	Hold	666	–	–	0.03%	258
2022 Q3	$178K	Hold	666	–	–	0.03%	222
2022 Q2	$136K	Hold	666	–	–	0.02%	254
2022 Q1	$140K	Sell	666 -20	-3%	-$4.35K	0.02%	291
2021 Q4	$165K	Buy	686 +16	+2%	+$4.11K	0.02%	284
2021 Q3	$190K	Hold	670	–	–	0.03%	285
2021 Q2	$232K	Hold	670	–	–	0.03%	247
2021 Q1	$187K	Sell	670 -91	-12%	-$24.5K	0.03%	263
2020 Q4	$186K	Buy	761 +89	+13%	+$23K	0.03%	246
2020 Q3	$191K	Sell	672 -1,435	-68%	-$400K	0.03%	221
2020 Q2	$564K	Hold	2,107	–	–	0.08%	136
2020 Q1	$667K	Buy	2,107 +154	+8%	+$46.7K	0.11%	116
2019 Q4	$580K	Sell	1,953 -116	-6%	-$32.2K	0.06%	154
2019 Q3	$482K	Hold	2,069	–	–	0.06%	158
2019 Q2	$484K	Sell	2,069 -70	-3%	-$16.2K	0.06%	151
2019 Q1	$506K	Buy	2,139 +186	+10%	+$58.6K	0.06%	144
2018 Q4	$567K	Hold	1,953	–	–	0.09%	131
2018 Q3	$690K	Hold	1,953	–	–	0.1%	115
2018 Q2	$567K	Hold	1,953	–	–	0.09%	132
2018 Q1	$535K	Hold	1,953	–	–	0.09%	129
2017 Q4	$622K	Hold	1,953	–	–	0.09%	113
2017 Q3	$612K	Hold	1,953	–	–	0.09%	103
2017 Q2	$530K	Hold	1,953	–	–	0.08%	109
2017 Q1	$534K	Hold	1,953	–	–	0.08%	109
2016 Q4	$554K	Sell	1,953 -50	-2%	-$14.8K	0.08%	110
2016 Q3	$627K	Hold	2,003	–	–	0.09%	100
2016 Q2	$484K	Hold	2,003	–	–	0.07%	128
2016 Q1	$521K	Hold	2,003	–	–	0.07%	117
2015 Q4	$614K	Hold	2,003	–	–	0.09%	99
2015 Q3	$584K	Hold	2,003	–	–	0.1%	89
2015 Q2	$809K	Hold	2,003	–	–	0.13%	69
2015 Q1	$845K	Sell	2,003 -264	-12%	-$104K	0.13%	64
2014 Q4	$770K	Hold	2,267	–	–	0.1%	92
2014 Q3	$750K	Hold	2,267	–	–	0.1%	89
2014 Q2	$715K	Sell	2,267 -200	-8%	-$60.2K	0.1%	100
2014 Q1	$755K	Buy	2,467 +250	+11%	+$79.4K	0.12%	89
2013 Q4	$620K	Hold	2,217	–	–	0.1%	116
2013 Q3	$534K	Sell	2,217 -90	-4%	-$20.1K	0.09%	119
2013 Q2	$496K	Buy	+2,307	New	+$493K	0.09%	120

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Manchester Capital Management's BIIB Position: Q1 2026 in Review

Manchester Capital Management reduced its Biogen (BIIB) stake by 0.33% in Q1 2026, selling an estimated $553 and leaving 901 shares worth $165K. The position accounts for 0.02% of the portfolio, ranked #294.

Manchester Capital Management first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $845K in Q1 2015. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Manchester Capital Management held 901 shares of Biogen worth $165K as of Q1 2026.
Manchester Capital Management sold 3 Biogen shares in Q1 2026, an estimated $553.
Biogen made up 0.02% of Manchester Capital Management's portfolio in Q1 2026, its #294 holding.
Manchester Capital Management first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
Manchester Capital Management's Biogen position peaked at $845K in Q1 2015.
1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.